一种使用经会阴超声的新型磁共振成像/超声融合前列腺活检技术:初步经验
该研究报道了一种新型全经会阴前列腺融合活检技术的初步经验,该技术使用置于会阴皮肤的无约束超声探头引导经会阴途径插入的活检针。2018年6月至2022年4月期间,76例患者接受了78次经会阴活检,同一会话中分别行常规经直肠超声引导的经会阴融合活检和全经会阴超声融合活检。在46例后续患者的92个MRI可见病灶中,常规经会阴活检诊断Grade组≥2癌24/92个病灶(26%),全经会阴活检诊断25/92个病灶(27%)(P=1.00),两种方法间Grade组≥2癌的一致率为73/92(79%)。结论认为全经会阴活检可行,前列腺癌检出率与常规经会阴活检相当。
要点
- 全经会阴前列腺融合活检使用会阴皮肤上的无约束超声探头引导活检针,技术可行。
- 在92个MRI可见病灶中,全经会阴活检与常规经会阴活检的Grade组≥2癌检出率分别为27%和26%(P=1.00)。
- 两种方法间Grade组≥2癌的一致率为79%(73/92个病灶)。
核心结论
- 全经会阴活检可行,其前列腺癌检出率可能与常规经会阴活检相当。
研究设计与样本
- 单中心学术中心研究,纳入2018年6月至2022年4月期间76例已知或疑似前列腺癌患者,共78次经会阴活检会话;同一会话中行常规经直肠超声引导的经会阴融合活检(网格或徒手装置)和全经会阴超声融合活检;经过30例患者的改进期后,在46例后续患者中取样92个MRI可见前列腺病灶,并对改进期中2例患者重复活检。
主要发现
- 常规经会阴活检诊断Grade组≥2癌24/92个病灶(26%)(网格装置17个病灶,徒手装置7个病灶),全经会阴活检诊断25/92个病灶(27%)(P=1.00)。
- 两种方法间Grade组≥2癌的一致率为73/92(79%)。
关键数值与推荐
- 全经会阴活检与常规经会阴活检的Grade组≥2癌检出率分别为27%(25/92)和26%(24/92),P=1.00。
- 两种方法间Grade组≥2癌的一致率为79%(73/92)。
临床怎么用
- 作者认为全经会阴活检可行,可能以与常规经会阴活检相当的检出率检测前列腺癌。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report an initial experience with a novel, "fully" transperineal (TP) prostate fusion biopsy using an unconstrained ultrasound transducer placed on the perineal skin to guide biopsy needles inserted via a TP approach. METHODS: Conventional TP prostate biopsies for detection of prostate cancer have been performed with transrectal ultrasound, requiring specialized hardware, imposing limitations on needle trajectory, and contributing to patient discomfort. Seventy-six patients with known or suspected prostate cancer underwent 78 TP biopsy sessions in an academic center between June 2018 and April 2022 and were included in this study. These patients underwent TP prostate fusion biopsy using a grid or freehand device with transrectal ultrasound as well as TP prostate fusion biopsy using TP ultrasound in the same session. Per-session and per-lesion cancer detection rates were compared for conventional and fully TP biopsies using Fisher exact and McNemar's tests. RESULTS: After a refinement period in 30 patients, 92 MRI-visible prostate lesions were sampled in 46 subsequent patients, along with repeat biopsies in 2 of the 30 patients from the refinement period. Grade group ≥2 cancer was diagnosed in 24/92 lesions (26%) on conventional TP biopsy (17 lesions with grid, 7 with freehand device), and in 25/92 lesions (27%) on fully TP biopsy (P = 1.00), with a 73/92 (79%) rate of agreement for grade group ≥2 cancer between the two methods. CONCLUSION: Fully TP biopsy is feasible and may detect prostate cancer with detection rates comparable to conventional TP biopsy.
引用
- Enders JJ, Pinto PA, Xu S, et al. A Novel Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy Technique Using Transperineal Ultrasound: An Initial Experience. Urology. 2023. PMID: 37572884. doi:10.1016/j.urology.2023.06.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。